Table 4.
Multivariate analysis of prognosis factors associated with post-cryoablation survival in 120 patients with advanced HCC
|
Variables |
Multivariate |
||
|---|---|---|---|
| RR | CI 95% | P | |
|
Time to progression | |||
| Age |
0.465 |
0.201-1.128 |
0.082 |
| ECOG PS |
1.428 |
1.014-1.823 |
0.221 |
| Child-Pugh class |
1.126 |
1.051-1.517 |
0.329 |
| Tumor diameter |
0.721 |
0.437-1.207 |
0.221 |
| Tumor number |
0.938 |
0.783-1.178 |
0.746 |
| Tumor differentiation |
1.246 |
0.752-1.972 |
0.384 |
| MACC1 mRNA expression |
2.103 |
1.378-2.801 |
0.005 |
| HCC thrombus in PV |
1.033 |
0.662-1.734 |
0.881 |
|
Overall survival | |||
| Age |
0.569 |
0.301-1.216 |
0.278 |
| ECOG PS |
1.452 |
1.021-2.033 |
0.026 |
| Child-Pugh class |
1.127 |
1.038-1.861 |
0.105 |
| Tumor diameter |
1.221 |
0.332-1.325 |
0.763 |
| Tumor number |
0.873 |
0.661-1.148 |
0.332 |
| Tumor differentiation |
1.142 |
0.673-2.116 |
0.736 |
| MACC1 |
1.842 |
1.201-2.514 |
0.011 |
| HCC thrombus in PV | 1.058 | 0.483-2.354 | 0.825 |
PV: portal vein.